|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY IN PATIENTS WHOSE RENAL FUNCTION DEPENDS UPON ACTIVITY OF RENIN-ANGIOTENSIN-ALDOSTERON SYSTEM EG. PATIENTS WITH SEVERE CHF
|
CO-ADMINISTRATION MAY POTENTIATE HYPERTENSIVE EFFECT OF THE DRUG
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
INCREASED RISK OF HYPERKALEMIA
|
INCREASED RISK OF HYPERKALEMIA
|
INCREASED RISK OF HYPERKALEMIA
|
ALISKIREN PLASMA CONCENTRATION IS REDUCED UP TO 50%
|